Digestive Drugs Market Size, Trends, and Forecast Analysis (2024-2032)

Digestive drugs market is concerned with medications developed to address issues concerning the GI system. Prokinetics are intended for the management of a wide range of ailments, ranging from gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), inflammatory bowel disease (IBD, specifically Crohn’s disease and ulcerative colitis) to constipation, diarrhoea and peptic ulcers. Pharmacotherapy of gastrointestinal tract involves drugs that help regulate the physical functions, bring down inflammation, control acid secretion, or supress the symptoms. This is because more people are developing digestive disorders due to the unhealthy life styles, lack of exercise and the increasing stress levels. Biologics and targeted therapies are the trends that continue to define the market as they give better results coupled with fewer side effects than generic medicines.